CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Advertisement

Solstice

TekniPlex Healthcare Retains David Schnur Associates (DSA)

DSA will support customers for Interventional Devices products and services, including complex custom extrusions, precision metal workings and complex design & development projects for implantable components and catheter assembly.

Wayne, PA,  – TekniPlex Healthcare,whichutilizes advanced materials science expertise to help deliver better patient outcomes, has engaged David Schnur Associates (DSA), a global supplier of outsourced technical sales and marketing services for the medical device industry, to represent TekniPlex Healthcare’s fast-growing interventional devices category. DSA’s team of interventional devices technical experts spans key markets for TekniPlex Healthcare, including North and Latin America, Europe, Israel and Turkey.  

Partnering with DSA provides TekniPlex Healthcare with a ready-made extension of its internal sales, marketing and customer management teams for selected interventional device products and services. Working with DSA’s turnkey technical experts will afford TekniPlex Healthcare a streamlined, focused approach to expanding its evolving medical device business which, moving forward, will be subdivided into two customer service categories:

  • TekniPlex Healthcare will continue to internally handle all customer engagement for its Advanced Medical Solutions portfolio, which spans a variety of extruded tubing solutions, molded parts and medical device compounds outside the sphere of interventional devices, as well as assembly and packaging services for such products.
  • DSA will support customer engagement activities for TekniPlex Healthcare’s Interventional Devices products and services, including precision polymer and metal components, complicated custom extrusions, and complex design and development projects involving implantable components (such as stents, stent grafts and transcatheter valves), catheter constructions, delivery systems, and molding and assembly projects associated with interventional devices.

The decision to partner with DSA reflects TekniPlex Healthcare’s rapid, extensive capabilities additions in the medical device sector. With eclectic skill sets for designing and manufacturing Class III implantable components and delivery systems, TekniPlex Healthcare is among the few medical device CDMOs offering comprehensive, ideation-to-completion product development for endovascular stents, heart valves and catheter delivery systems, among other categories. The company’s sweeping capabilities include high-precision, tight-tolerance development and prototyping for critical metal components necessary in interventional cardiology, radiology, neurovascular, peripheral vascular, structural heart, electrophysiology and other minimally invasive therapies.

TekniPlex Healthcare’s array of services supports customers from early ideation stages through product development, prototyping, clinical trials, testing, new product introduction and full production of catheter-based devices. This includes precision secondary processes and cleanroom assembly of Class II and Class III implantable components.

“Considering DSA’s exemplary reputation as true medical device specialists, partnering with their team of technical experts extends our in-house team of talented sales, marketing and customer management professionals in a truly plug-and-play fashion,” said Bryan Wesselmann, VP of Sales and Marketing for TekniPlex Healthcare. “As our capabilities in the interventional devices space continue to expand and diversify to address an ever-shifting landscape, working with the DSA team makes TekniPlex Healthcare even more prepared to provide expertise-driven engineering services to our global customer base.”

“TekniPlex Healthcare’s Interventional Devices portfolio is a tremendous resource with strong niche technologies in complex extrusion, metal components and nitinol fabrication,” said DSA CEO Barry Schnur. “We’re excited to partner with TekniPlex Healthcare to support existing customers and to expand access to this collection of specialized interventional device solutions.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026